ImmunityBio, Inc. (FRA:26CA)
Germany flag Germany · Delayed Price · Currency is EUR
1.964
+0.104 (5.59%)
At close: Dec 4, 2025

ImmunityBio Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Market Capitalization
1,9391,8053,0321,9422,127-
Upgrade
Market Cap Growth
-41.30%-40.46%56.14%-8.68%--
Upgrade
Enterprise Value
2,4582,6653,5122,5042,357-
Upgrade
Last Close Price
1.962.694.584.545.46-
Upgrade
PS Ratio
27.56126.775388.888648.472589.53-
Upgrade
PB Ratio
-4.35-3.83-5.72-4.61-9.92-
Upgrade
EV/Sales Ratio
34.64187.096241.2011149.272870.55-
Upgrade
Debt / Equity Ratio
-1.65-1.62-1.51-1.61-2.66-2.33
Upgrade
Asset Turnover
0.190.030.000.000.000.00
Upgrade
Quick Ratio
5.102.784.630.220.861.44
Upgrade
Current Ratio
5.773.365.050.280.911.64
Upgrade
Return on Assets (ROA)
-36.89%-48.48%-52.11%-52.73%-57.48%-72.72%
Upgrade
Return on Capital (ROIC)
-53.22%-71.77%-78.80%-64.47%-70.68%-106.38%
Upgrade
Return on Capital Employed (ROCE)
-56.50%-104.90%-81.00%253.20%-317.70%-130.90%
Upgrade
Earnings Yield
-15.32%-22.13%-17.40%-20.07%-14.34%-
Upgrade
FCF Yield
-14.28%-21.30%-11.85%-20.03%-12.73%-
Upgrade
Buyback Yield / Dilution
-25.58%-37.71%-27.19%-2.74%-3.23%-2.93%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.